Y90 radioembolization is a minimally invasive, outpatient procedure that extends the lives of liver cancer patients with incurable tumors and increases their well-being. A high dose of radiation can be focused directly inside tumors while nearby healthy tissue receives a minimal dose resulting in fewer or no side effects.
Interventional radiologists catheterize the hepatic artery and infuse a tumor with microscopic resin beads containing the radioactive isotope yttrium Y90. Patients with hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and certain liver metastatic cancers, including colorectal, breast, and neuroendocrine cancer, respond well to this treatment.
Y90 radioembolization is performed as one planning procedure followed by one or two treatment procedures. A Y90 radiation dose is gradually delivered within about 10 days, and it is limited to a short distance, so patients do not have to worry about exposing close contacts to radiation after treatment. Y90 radioembolization slows the growth of the disease and alleviates symptoms but does not cure the disease.
Learn more: WVUCancer.org
For questions or to refer a patient, call 855-WVU-CARE.